Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCLR 131 Demonstrates High Rate of Activity in a Phase 1, Dose Escalation Study in Patients with Relapsed or Refractory Multiple Myeloma (RRMM).AuthorsLongcor, Jarrod; Ailawadhi, Sikander; Oliver, Kate; Callander, Natalie; Stiff, PatrickPublicationClinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pe356ISSN2152-2650Publication typeArticleDOI10.1016/j.clml.2019.09.589